A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-120 and AD-120A

NCT06916130 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux Disease (GERD)

Interventions

DRUG: AD-120A
DRUG: AD-120

Sponsor

Addpharma Inc.